CT-2106: Difference between revisions
Jump to navigation
Jump to search
(CSV import) |
(CSV import) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{ | {{Definitions | ||
|Short definition | |Term=CT-2106 | ||
|Short definition=CT-2106 - A form of the cancer drug camptothecin that may have fewer side effects and work better than camptothecin. It is being studied in the treatment of cancer. | |||
|Type=Cancer terms | |||
|Specialty=Oncology | |||
|Language=English | |||
|Source=NCI | |||
}} | }} | ||
CT-2106 - A form of the cancer drug camptothecin that may have fewer side effects and work better than camptothecin. It is being studied in the treatment of cancer. It is a type of DNA topoisomerase inhibitor. Also called polyglutamate camptothecin {{dictionary-stub}} [[Category:Dictionary of medicine]] | |||
Latest revision as of 04:35, 11 January 2023
| CT-2106 | |
|---|---|
| Term | CT-2106 |
| Short definition | CT-2106 - A form of the cancer drug camptothecin that may have fewer side effects and work better than camptothecin. It is being studied in the treatment of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
CT-2106 - A form of the cancer drug camptothecin that may have fewer side effects and work better than camptothecin. It is being studied in the treatment of cancer. It is a type of DNA topoisomerase inhibitor. Also called polyglutamate camptothecin
External links
- Medical encyclopedia article on CT-2106
- Wikipedia's article - CT-2106
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski